ATM and cancer: However, prior work demonstrates good agreement between cancer registry-reported HR status and HR status determined by a single academic reference laboratory.23 Finally, deleterious missense variants are rare relative to protein-truncating variants in ATM and BRCA1 or BRCA2. As a result, statistical power to assess their relationship to CBC HR status was limited.